Publication | Closed Access
A mutation in CYP2C9 is responsible for decreased metabolism of losartan.
25
Citations
0
References
1996
Year
GeneticsMolecular BiologyMolecular GeneticsPharmacotherapyDecreased MetabolismPre-clinical PharmacologyPharmacological StudyBiochemical GeneticsMetabolic SignalingMolecular PhysiologyBiochemistryClinical TherapeuticPharmacologyMolecular MedicinePharmacodynamicsGenetic DisorderNatural SciencesClinical PharmacologyMetabolismMedicineDrug Discovery
Clinical Pharmacology & Therapeutics (1996) 59, 215–215; doi: 10.1038/sj.clpt.1996.361